Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2009
Insulin-like growth factors and leukocyte telomere length: the cardiovascular health studyRobert C Kaplan, Annette L Fitzpatrick, Michael N Pollak, et al.
Mechanisms of Ageing and Development|November 17, 2009
Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjectsMichelangela Barbieri, Giuseppe Paolisso, Masayuki Kimura, et al.
Geroscience|August 29, 2018
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers WorkgroupJamie N Justice, Luigi Ferrucci, Anne B Newman, et al.
Cancer Research|August 19, 2007
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancerBrian M Wolpin, Dominique S Michaud, Edward L Giovannucci, et al.
FEBS Open Bio|March 18, 2022
Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cellsOro Uchenunu, Alexander V Zhdanov, Phillipe Hutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptorJohann S de Bono, Gerhardt Attard, Alex Adjei, et al.
Breast Cancer Research and Treatment|April 27, 2016
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14Judith-Anne W Chapman, Dennis C Sgroi, Paul E Goss, et al.
Cancer Research|October 21, 2010
Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomasJenny C Potratz, Darren N Saunders, Daniel H Wai, et al.
World Journal of Clinical Oncology|December 11, 2014
Competing risks of death in younger and older postmenopausal breast cancer patientsJudy-Anne W Chapman, Kathleen I Pritchard, Paul E Goss, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2009
Insulin-like growth factors and leukocyte telomere length: the cardiovascular health studyRobert C Kaplan, Annette L Fitzpatrick, Michael N Pollak, et al.
Mechanisms of Ageing and Development|November 17, 2009
Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjectsMichelangela Barbieri, Giuseppe Paolisso, Masayuki Kimura, et al.
Geroscience|August 29, 2018
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers WorkgroupJamie N Justice, Luigi Ferrucci, Anne B Newman, et al.
Cancer Research|August 19, 2007
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancerBrian M Wolpin, Dominique S Michaud, Edward L Giovannucci, et al.
FEBS Open Bio|March 18, 2022
Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cellsOro Uchenunu, Alexander V Zhdanov, Phillipe Hutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptorJohann S de Bono, Gerhardt Attard, Alex Adjei, et al.
Breast Cancer Research and Treatment|April 27, 2016
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14Judith-Anne W Chapman, Dennis C Sgroi, Paul E Goss, et al.
Cancer Research|October 21, 2010
Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomasJenny C Potratz, Darren N Saunders, Daniel H Wai, et al.
World Journal of Clinical Oncology|December 11, 2014
Competing risks of death in younger and older postmenopausal breast cancer patientsJudy-Anne W Chapman, Kathleen I Pritchard, Paul E Goss, et al.
Pageof 18